NFKBIA and idiopathic pulmonary fibrosis: Our results validated the effectiveness of Shenfu injection in the treatment of IPF, and verified its mechanism as inhibiting inflammation and apoptosis as proposed by targeting NFKBIA, CASP3, and IL-1B (Figure 6).